Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials

Alphonse Ouédraogo, Daouda Ouattara, San Maurice Ouattara, Amidou Diarra, Emilie S Badoum, Alimatou Hema, Amidou Z Ouédraogo, Denise Hien, Edith C Bougouma, Issa Nébié, Valéry Bocquet, Michel Vaillant, Alfred B Tiono, Sodiomon B Sirima · 2024

Read Evaluating artesunate monotherapy and dihydroartemisinin-piperaquine as potential antimalarial options for prevaccination radical cures during future malaria vaccine field efficacy trials by Alphonse Ouédraogo, Daouda Ouattara, San Maurice Ouattara, Amidou Diarra, Emilie S Badoum, Alimatou Hema, Amidou Z Ouédraogo, Denise Hien, Edith C Bougouma, Issa Nébié, Valéry Bocquet, Michel Vaillant, Alfred B Tiono, Sodiomon B Sirima (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11656655.txt.

Description

Alphonse Ouédraogo and thirteen co-authors set two malaria drugs as pre-shot cleans for next shot trials. Their study appeared in twenty twenty-four. Live germs can blunt shot force, so clean first is weighed. Kids in a Burkina Faso zone were split by lot to one of two drug plans. Then they were watched for six months.

Five hundred thirteen kids aged past one to twelve were dosed. Near nine in ten were germ-free at three weeks, a tie tween arms. First back ills came late in the pair arm, and ill counts ran low there. The lone drug is backed for least trial sway.

Catalog record

CREATORAlphonse Ouédraogo, Daouda Ouattara, San Maurice Ouattara, Amidou Diarra, Emilie S Badoum, Alimatou Hema, Amidou Z Ouédraogo, Denise Hien, Edith C Bougouma, Issa Nébié, Valéry Bocquet, Michel Vaillant, Alfred B Tiono, Sodiomon B Sirima
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11656655

Browse the full library · About the Tower of Babel